• Home
  • Physicians
    • Physician Overview
    • Clinical Evidence
    • SENZA-RCT Design
    • HF10 Therapy Superiority
    • HF10 Therapy Benefits
    • Senza System
    • Product Manuals
    • Grants
    • Study Support
  • Patients
    • Patient Overview
    • Chronic Pain & Treatments
    • HF10 Therapy Advantages
    • Patient Experiences
    • FAQ
    • Existing Patients
  • Reimbursement
  • Newsroom
    • Press Releases
    • Events
    • Resources
  • Investors
    • Overview
    • Investor News
    • Stock Information
      • Stock Information
      • Covering Analysts
    • Financial Information
      • SEC Filings
      • Quarterly Financials
      • Annual Reports
    • Events & Presentations
      • Events
      • Presentations
    • Investor FAQs
  • About Us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Corporate Governance
    • Contact Us
      • Physician Inquiry
      • Patient Inquiry
      • General Inquiry
  • Careers
    • Main
    • Culture
    • Benefits
    • Opportunities
3aZEVvoRtp6McXy8TuIlR6lERn067Z
Home  >  Investors  >  Contact ir

hf10 therapy delivers

a significant advance in spinal cord stimulation.

  • Home
  • Physicians
    • Physician Overview
    • Clinical Evidence
    • SENZA-RCT Design
    • HF10 Therapy Superiority
    • HF10 Therapy Benefits
    • Senza System
    • Product Manuals
    • Grants
    • Study Support
  • Patients
    • Patient Overview
    • Chronic Pain & Treatments
    • HF10 Therapy Advantages
    • Patient Experiences
    • FAQ
    • Existing Patients
  • Reimbursement
  • Newsroom
    • Press Releases
    • Events
    • Resources
  • Investors
    • Overview
    • Investor News
    • Stock Information
      • Stock Information
      • Covering Analysts
    • Financial Information
      • SEC Filings
      • Quarterly Financials
      • Annual Reports
    • Events & Presentations
      • Events
      • Presentations
    • Investor FAQs
  • About Us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Corporate Governance
    • Contact Us
      • Physician Inquiry
      • Patient Inquiry
      • General Inquiry
  • Careers
    • Main
    • Culture
    • Benefits
    • Opportunities

Contact IR

Nevro Corp.
1800 Bridge Parkway,
Redwood City, CA 94065 U.S.A.

Investor Relations Contact: ir@nevro.com
General Inquiry: general-OUS@nevro.com
Clinical Inquiry: healthcare-OUS@nevro.com
Patient Inquiry: healthcare-OUS@nevro.com

Investor Email Alerts

Email Address *
Mailing Lists *


Unsubscribe

Quick Links

  • Contact ir >
  • email alerts >
  • Rss Feeds >
Nevro
  • Home
  • Physicians
    • Physician Overview
    • Clinical Evidence
    • SENZA-RCT Design
    • HF10 Therapy Superiority
    • HF10 Therapy Benefits
    • Senza System
    • Product Manuals
    • Grants
    • Study Support
  • Patients
    • Patient Overview
    • Chronic Pain & Treatments
    • HF10 Therapy Advantages
    • Patient Experiences
    • FAQ
    • Existing Patients
  • Reimbursement
  • Newsroom
    • Press Releases
    • Events
    • Resources
  • Investors
    • Overview
    • Investor News
    • Stock Information
      • Stock Information
      • Covering Analysts
    • Financial Information
      • SEC Filings
      • Quarterly Financials
      • Annual Reports
    • Events & Presentations
      • Events
      • Presentations
    • Investor FAQs
  • About Us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Corporate Governance
    • Contact Us
      • Physician Inquiry
      • Patient Inquiry
      • General Inquiry
  • Careers
    • Main
    • Culture
    • Benefits
    • Opportunities
  • Legal Notice |
  • Terms Of Use |
  • Patents |
  • Privacy |
  • Terms & Conditions
© 2019 Nevro Corp. All rights reserved.

Senza, Senza II, Senza Omnia, HF10, More, Nevro, Nevrocloud, Surpass and the Nevro, HF10, and Frequency Pairing Logos are trademarks of Nevro Corp.

Powered By Q4 Inc. 5.26.0.1
 
This site uses cookies to enhance user experience and analyze site usage. By clicking Accept you consent to the site's use of cookies.
Read More. Accept